医学
血管成形术
心脏病学
内科学
背景(考古学)
部分流量储备
气球
冠状动脉血流储备
血流动力学
流量(数学)
冠心病
冠状动脉疾病
介入心脏病学
血流
狭窄
作者
Chun‐Chin Chang,Jui-Yun Lee,Hsin Lin Chou,Weiting Sung,Ya-Wen Lu,Yi‐Lin Tsai,Hsin-I Teng,Ruey‐Hsing Chou,Jean‐Paul Aben,Po‐Hsun Huang
摘要
BACKGORUND: Drug-coated balloon (DCB) angioplasty offers a potential alternative to avoid permanent metallic stent implantation and the associated risk of in-stent restenosis. AIMS: This study aimed to evaluate the safety and effectiveness of DCB angioplasty for de novo coronary stenoses in real-world clinical practice. METHODS: This was a single-center, retrospective observational study. Between March 2017 and October 2023, patients who underwent DCB angioplasty for at least one de novo coronary stenosis were included. The primary endpoint was the device-oriented composite endpoint (DOCE), defined as a composite of cardiovascular death, device failure-related myocardial infarction, or device failure-related target lesion revascularization. Post-procedural angiography-derived fractional flow reserve (vFFR) was evaluated after DCB angioplasty in eligible patients with angiograms of adequate quality. RESULTS: A total of 255 de novo coronary stenoses undergoing DCB angioplasty were analyzed. Among the treated lesions, 92.5% were located in the main epicardial vessels. Cutting or scoring balloons and rotational atherectomy were employed for lesion preparation in 14.5% and 5.9% of lesions, respectively. The bailout stenting rate was 1.9%. During a follow-up duration of 558 ± 499 days, the primary endpoint, DOCE, occurred in 13 lesions (5.1%). Post-procedural vFFR was analyzable in 130 lesions. Residual stenosis ≤ 30% was achieved in only 39.1% of lesions, whereas 80.7% of lesions demonstrated a post-procedural vFFR ≥ 0.75. CONCLUSIONS: Patients undergoing DCB angioplasty for de novo coronary stenoses demonstrated favorable clinical outcomes during mid-term follow-up. The clinical utility of vFFR in the context of DCB angioplasty warrants further investigation in large-scale studies to determine its impact on clinical outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI